Cellular Dynamics: We Develop Human Cells
CDI Notebook - May 2015
TrendingDigital MediaArticlesCDI in the NewsUpcoming EventsApplications
CDI Notebook
Welcome to CDI Notebook
iCell Cardiomyocytes^2 Application: High-throughput Screening Compatible

iCell Cardiomyocytes2: High-throughput Screening Compatible. Perform effective screens in less time utilizing these newly available cardiomyocytes, optimized for faster recovery upon reanimation from cryopreservation, in 1536-well plates.


Digital Media
iPSC-cardiomyocytes Webinar Registration

Accurate Prediction of On- and Off-target Cardiotoxicity with Human iPSC-derived Cardiomyocytes (May 27). Hear about the practical implementation of iPSC-derived cardiomyocytes in toxicity testing applications and how these cells could save resources, increase productivity, and result in safer medicines.


Contact Us: MyCell Hepatocytes

Impairment of Type I But Not Type III IFN Signaling by Hepatitis C Virus Infection Influences Antiviral Responses in Primary Human Hepatocytes. Read how iCell Hepatocytes were used to study the effects of HCV replication on IFN signaling using donor serum-derived clinically relevant viral genotypes.

Friborg J, Ross-Macdonald P, et al. (2015) PLoS One.



Structural and Functional Screening in Human Induced-pluripotent Stem Cell-derived Cardiomyocytes Accurately Identifies Cardiotoxicity of Multiple Drug Types. Discover how researchers looked across a mixture of 24 compounds and used a combination of phenotypic and mechanistic interrogation techniques to stratify correctly all compounds without known risk and 16/18 of compounds with known liabilities.

Doherty KR, Talbert DR, et al. (2015) Tox Sci.


CDI in the News
Edison Awards Logo

2015 Edison Award Winner! MyCell Disease and Diversity Products. Innovate with these phenotypically relevant differentiated cells, recipient of a gold award in the area of Research & Education at the recent 2015 Edison Awards.



The Immortal Challenge. Discover how Cellular Dynamics and other stem cell companies are working hard to enable reproducible research.



Successful Closure of the TOB for Cellular Dynamics International Inc., a Leading U.S. Company in the Development and Manufacture of iPSCs. Learn how FUJIFILM Holdings Corporation plans to leverage the addition of Cellular Dynamics researchers and iPS cell-derived technology to its portfolio.


Upcoming Events
MEA Workshop Registration

North American MEA Workshop (May 15 | West Conshohocken, PA | Hosted by Cyprotex and Axion Biosystems). See researchers present their findings on using iPSC-derived cardiomyocytes with multielectrode array technology.


Wanted: Your Presentation/Paper. Reward: Free Cells!
iCell Cardiomyocytes Application: Non-invasive Video Interrogation

iCell Cardiomyocytes: Non-invasive Video Interrogation. Learn how a recently released methodology facilitates the analysis of cardiomyocyte function.


SOT 2015 Posters Download

SOT 2015 Posters. Access these posters to see how iCell and MyCell technology drive screening applications:

 Categorization of Petroleum Substances Through High-content Screening of Induced Pluripotent Stem Cell (iPSC)-derived Cardiomyocytes and Hepatocytes

  Endothelial Sprouting Arrays for Screening Vascular Disrupting Compounds

  In Vitro Toxicology Testing Using Human Induced Pluripotent Stem Cell-derived Cardiomyocytes to Predict Tobacco Smoking-related Cardiovascular Diseases

  Mcl-1 Knockdown Causes a Sub-lethal Injury in Cultured Human iPSC-cardiomyocytes

  Transmembrane Potential Measurements in Cardiac 3D Microtissues Derived from Human Stem Cells

  Using Human-induced Pluripotent Stem Cells (iPSC) in High-content Screening (HCS) to Prioritize Chemicals for Developmental Neurotoxicity Testing


Follow UsCDI TwitterCDI LinkedInCDI FacebookCDI Youtube

© 2015 FUJIFILM Cellular Dynamics Inc., 525 Science Drive, Madison, WI 53711
+1 (608) 310-5100 or toll-free (877) 310-6688